These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 35455315)
1. Factors Associated with Non-Severe Adverse Reactions after Vaccination against SARS-CoV-2: A Cohort Study of 908,869 Outpatient Vaccinations in Germany. Loosen SH; Bohlken J; Weber K; Konrad M; Luedde T; Roderburg C; Kostev K Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455315 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090 [TBL] [Abstract][Full Text] [Related]
4. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A Front Immunol; 2021; 12():780594. PubMed ID: 34925359 [TBL] [Abstract][Full Text] [Related]
5. Small fiber neuropathy as a complication of SARS-CoV-2 vaccinations. Finsterer J J Family Med Prim Care; 2022 Jul; 11(7):4071-4073. PubMed ID: 36387712 [TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic. Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359 [TBL] [Abstract][Full Text] [Related]
7. COVID-19: Vaccination Side Effects and Sick Leave in Frontline Healthcare-Workers-A Web-Based Survey in Germany. Nohl A; Brune B; Weichert V; Standl F; Stang A; Dudda M Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335043 [TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
14. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
15. Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers. Kim YK; Minn D; Chang SH; Suh JS Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214652 [TBL] [Abstract][Full Text] [Related]
16. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia. Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228 [No Abstract] [Full Text] [Related]
17. Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines-A Case Series. Girbardt C; Busch C; Al-Sheikh M; Gunzinger JM; Invernizzi A; Xhepa A; Unterlauft JD; Rehak M Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835280 [TBL] [Abstract][Full Text] [Related]
18. Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study. Piros ÉA; Cseprekál O; Görög A; Hidvégi B; Medvecz M; Szabó Z; Olajos F; Barabás E; Galajda N; Miheller P; Holló P Dermatol Ther; 2022 May; 35(5):e15408. PubMed ID: 35218276 [TBL] [Abstract][Full Text] [Related]
19. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2. Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606 [TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study. Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH; BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]